Oracle Drug Software Infringes Patent, Suit Says
DrugLogic Inc. has accused Oracle Corp., which recently acquired two of DrugLogic's competitors in the market for drug safety surveillance software, of breaching a marketing agreement and infringing a patent for...To view the full article, register now.
Already a subscriber? Click here to view full article